Guard Therapeutics International AB (OSTO:GUARD) Institutional Ownership: 3.79% (As of Aug. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:GUARD Guard Therapeutics International AB OSTO:GUARD
19 GF Score
Price kr1.39
! 1 Warning Sign
View Full Analysis

What is Guard Therapeutics International AB Institutional Ownership?

Guard Therapeutics International AB OSTO:GUARD +4.21% 19 Institutional Ownership is 3.79% as of Aug. 09, 2026. GuruFocus rates OSTO:GUARD with a GF Score™ of 19/100. The stock has 1 warning sign investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Guard Therapeutics International AB's institutional ownership is 3.79%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Guard Therapeutics International AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Guard Therapeutics International AB's Float Percentage Of Total Shares Outstanding is 0.00%.

Guard Therapeutics International AB Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Guard Therapeutics International AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guard Therapeutics International AB Institutional Ownership Chart

Guard Therapeutics International AB Historical Data

The historical data trend for Guard Therapeutics International AB can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 13.58 13.74 3.79 3.79 3.79 3.79 3.79 3.79 3.79 3.79
OSTO:GUARD
19GF Score
Guard Therapeutics International AB OSTO:GUARD
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guard Therapeutics International AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 3.79% mean?
Guard Therapeutics International AB (OSTO:GUARD) has a Institutional Ownership of 3.79% as of Aug. 09, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Guard Therapeutics International AB and its competitors.
Is Guard Therapeutics International AB's Institutional Ownership too high?
Guard Therapeutics International AB's current Institutional Ownership is 3.79%. Overall, Guard Therapeutics International AB has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Guard Therapeutics International AB's Institutional Ownership compare to VRTX and REGN?
Guard Therapeutics International AB's Institutional Ownership of 3.79% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Guard Therapeutics International AB and its competitors. Guard Therapeutics International AB's current Institutional Ownership is 3.79%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guard Therapeutics International AB stock overvalued right now?
Guard Therapeutics International AB (OSTO:GUARD) has a current Institutional Ownership of 3.79%. The current Institutional Ownership is 3.79%. Guard Therapeutics International AB's overall GF Score™ is 19/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Guard Therapeutics International AB (OSTO:GUARD), the current Institutional Ownership is 3.79% as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Guard Therapeutics International AB Business Description

Other Exchanges 5LH0:Germany
Address Scheelevagen 22, Lund, SWE, 223 63
Guard Therapeutics International AB is engaged in developing and commercializing the lead drug candidate ROSgard, and thereby contribute to the better and less harmful treatment of acute kidney injuries.
19GF Score

Get the complete analysis for OSTO:GUARD

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.39
Price